Adrian Ion Bot
CIK: 0002101801
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)1 (100.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
RNAC
Cartesian Therapeutics, Inc.
Director
Discretionary Trading P&L
Holdings
About Bot Adrian Ion
Bot Adrian Ion (SEC CIK 0002101801) files insider reports with the SEC as Director of Cartesian Therapeutics, Inc. (RNAC).
Signal8 holds 2 ownership filings by Bot Adrian Ion (1 Form 3, 1 Form 4), filed on Dec 18, 2025. Those filings report 1 transaction, the latest on Dec 16, 2025. Signal8's Form 4 history starts in Sep 2024.
The business address on Bot Adrian Ion's filings is in FREDRICK, MD.
Recent filings by Bot Adrian Ion
- Dec 16, 2025: Grant or award of RNAC shares (Form 4, code A).
Other insiders filing for Cartesian Therapeutics, Inc. (RNAC)
- Hoge Elizabeth, 10% Owner
- Kalayoglu Murat, 10% Owner
- Singer Michael, Director
- Brunn Carsten, President and CEO
- Miljkovic Milos, Chief Medical Officer
- Davis Blaine, Chief Financial Officer